Found: 95
Select item for more details and to access through your institution.
Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: The ucla experience.
- Published in:
- Journal of Surgical Oncology, 1995, v. 60, n. 4, p. 262, doi. 10.1002/jso.2930600410
- By:
- Publication type:
- Article
Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma.
- Published in:
- BJU International, 2011, v. 108, n. 5, p. 665, doi. 10.1111/j.1464-410X.2010.09957.x
- By:
- Publication type:
- Article
The role of molecular markers in the staging of renal cell carcinoma.
- Published in:
- BJU International, 2007, v. 99, p. 1208, doi. 10.1111/j.1464-410X.2007.06812.x
- By:
- Publication type:
- Article
Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
- Published in:
- BJU International, 2007, v. 99, n. 4, p. 821, doi. 10.1111/j.1464-410X.2006.06729.x
- By:
- Publication type:
- Article
Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.
- Published in:
- BJU International, 2005, v. 96, n. 4, p. 483, doi. 10.1111/j.1464-410X.2005.05670.x
- By:
- Publication type:
- Article
Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma.
- Published in:
- BJU International, 2005, v. 96, n. 3, p. 281, doi. 10.1111/j.1464-410X.2005.05615.x
- By:
- Publication type:
- Article
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 2, p. 167, doi. 10.1016/j.clgc.2020.10.005
- By:
- Publication type:
- Article
Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Targeted therapy for sarcomas.
- Published in:
- Biologics: Targets & Therapy, 2014, v. 8, p. 91, doi. 10.2147/BTT.S26555
- By:
- Publication type:
- Article
Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?
- Published in:
- 1989
- By:
- Publication type:
- journal article
Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Interferon in renal cell carcinoma. The UCLA experience.
- Published in:
- Cancer (0008543X), 1987, v. 59, n. S3, p. 610, doi. 10.1002/1097-0142(19870201)59:3+<610::AID-CNCR2820591306>3.0.CO;2-F
- By:
- Publication type:
- Article
Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells.
- Published in:
- Molecular Cancer, 2003, v. 2, p. 35, doi. 10.1186/1476-4598-2-35
- By:
- Publication type:
- Article
The Evolving Immunotherapeutic Landscape in Renal Cell Carcinoma.
- Published in:
- Oncology Issues, 2021, v. 36, n. 2, p. 74, doi. 10.1080/10463356.2021.1879589
- By:
- Publication type:
- Article
A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
- Published in:
- Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-13196-4
- By:
- Publication type:
- Article
First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?
- Published in:
- Drugs, 2022, v. 82, n. 4, p. 439, doi. 10.1007/s40265-022-01683-6
- By:
- Publication type:
- Article
Recent Advances in the Medical Treatment of Recurrent or Metastatic Renal Cell Cancer.
- Published in:
- Drugs, 2017, v. 77, n. 1, p. 17, doi. 10.1007/s40265-016-0665-1
- By:
- Publication type:
- Article
Novel Treatment Advances and Approaches in the Management of Advanced Renal Cell Carcinoma (RCC).
- Published in:
- Journal of Managed Care Medicine, 2018, v. 21, n. 4, p. 79
- By:
- Publication type:
- Article
Myeloid Clusters Are Associated with a Pro-Metastatic Environment and Poor Prognosis in Smoking-Related Early Stage Non-Small Cell Lung Cancer
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0065121
- By:
- Publication type:
- Article
A Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054918
- By:
- Publication type:
- Article
Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0035661
- By:
- Publication type:
- Article
G250: A carbonic anhydrase IX monoclonal antibody.
- Published in:
- Current Oncology Reports, 2005, v. 7, n. 2, p. 109, doi. 10.1007/s11912-005-0036-7
- By:
- Publication type:
- Article
Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 9, p. 528, doi. 10.46883/onc.2021.3509.0528
- By:
- Publication type:
- Article
Second-Line Therapies in the Changing Landscape of First-Line Therapies for Metastatic Clear Cell Renal Cell Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 6, p. 306, doi. 10.46883/onc.2021.3506.0306
- By:
- Publication type:
- Article
Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 3, p. 119, doi. 10.46883/onc.2021.3503.0119
- By:
- Publication type:
- Article
Third-Line Treatment Options for Kidney Cancer.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 9, p. 813
- By:
- Publication type:
- Article
Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 3, p. 290
- By:
- Publication type:
- Article
Evolving Role of Novel Targeted Agents in Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 10, p. 1175
- By:
- Publication type:
- Article
Novel approaches in the therapy of metastatic renal cell carcinoma.
- Published in:
- World Journal of Urology, 2005, v. 23, n. 3, p. 202, doi. 10.1007/s00345-004-0466-0
- By:
- Publication type:
- Article
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex.
- Published in:
- World Journal of Urology, 2000, v. 18, n. 2, p. 152, doi. 10.1007/s003450050189
- By:
- Publication type:
- Article
An association between renal cell carcinoma and lymphoid malignancies: A case series of eight patients.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 11, p. 2421, doi. 10.1002/(SICI)1097-0142(19961201)78:11<2421::AID-CNCR21>3.0.CO;2-1
- By:
- Publication type:
- Article
Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 5, p. 998, doi. 10.1002/(SICI)1097-0142(19960901)78:5<998::AID-CNCR9>3.0.CO;2-8
- By:
- Publication type:
- Article
In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment.
- Published in:
- 1991
- By:
- Publication type:
- journal article
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 1, p. 178, doi. 10.1007/s10637-013-0045-6
- By:
- Publication type:
- Article
Dendritic cell-based immunotherapy of renal cell carcinoma.
- Published in:
- Current Urology Reports, 2001, v. 2, n. 1, p. 46, doi. 10.1007/s11934-001-0025-9
- By:
- Publication type:
- Article
Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Treatment of patients with metastatic renal cell cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 10, p. 2375, doi. 10.1002/cncr.22260
- By:
- Publication type:
- Article
Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 11, p. 2400
- By:
- Publication type:
- Article
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 12, p. 2517
- By:
- Publication type:
- Article
Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 12, p. 2566
- By:
- Publication type:
- Article
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 9, p. 1863
- By:
- Publication type:
- Article
Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-alpha for the treatment of patients with advanced renal cell carcinoma: a southwest oncology group Phase II study.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Annexin-I as a potential target for green tea extract induced actin remodeling.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 1, p. 111, doi. 10.1002/ijc.22164
- By:
- Publication type:
- Article
Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.
- Published in:
- International Journal of Cancer, 2003, v. 107, n. 2, p. 256, doi. 10.1002/ijc.11379
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 11, p. 1684, doi. 10.2967/jnumed.111.095257
- By:
- Publication type:
- Article
Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 739, doi. 10.1007/s00280-014-2539-0
- By:
- Publication type:
- Article